Clinical trial
A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough (FORTITUDE)
NCT07288528 is registered in ClinicalTrials.gov with McMaster University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough (FORTITUDE)
- Lead sponsor
- McMaster University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- October 1, 2029
- Enrollment
- 124 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
chronic cough, cough, cough hypersensitivity syndrome, refractory chronic cough, unexplained chronic cough